Ludovic Mure completed his MS in Neuroscience at the University of Lyon, France, and his Ph.D. in the laboratory of Dr. Howard Cooper at the SRBI (INSERM) where he investigated the recently discovered melanopsin, a photopigment expressed by a subset of retinal ganglion cells and rendering them intrinsically photosensitive (ipRGCs).
He pursued in this very exciting and fast-moving field by joining the lab of Satchin Panda (The Salk Institute, San Diego, US). As a postdoc, he explored the non-visual responses to light in particular the relationship between the circadian clock and light. He found that melanopsin unique properties relied on both its structure and its binding partners. Then, in an exceptional collaborative project between INSERM, the Salk Institute, and the Institute of Primate Research (Kenya), he established the first rhythmic transcriptome of a diurnal primate. This study unveiled the unique features of primate rhythmic gene expression and unveiled the importance of the natural light-dark cycles for gene expression. Recently, together with F. Vinberg (U. of Utah) and A. Hanneken (Scripps Institute), he developed a human retina preparation that preserves the function of each photoreceptive system for several hours after the death of the donors and was able to record for the first time human ipRGCs and to characterize their responses, sensitivity, spectra, and functional diversity.
Finally, in 2021, to transition to an independent research position in Europe, he joined the labs of Profs. Kleinlogel (U. of Bern) and Adamantidis (Department for Neurology, Inselspital) as a Velux Stiftung fellow to dissect ipRGCs circuits in the retina and the brain, in health and disease. In 2023, he joined the Department of Ophthalmology of the Inselspital in Bern (Switzerland) as a group leader.
Arianna Cella obtained her bachelor's degree in Biology at Urbino University. She then moved to Trieste, where she graduated in Neuroscience in 2023 with a thesis on time perception entitled "Duration perception encoding mechanisms in the auditory and tactile modalities". There she obtained a scholarship at SISSA, where she worked with prof. Matthew Diamond in the Tactile Perception and Learning Lab. She is now a PhD student at the University of Bern, working under Dr. Mure's supervision.
Qiuyu Zhuang completed her integrated bachelor's and master’s program in Clinical Medicine at Southeast University. During her master’s training, she completed a 3-year standardized residency at the Department of Ophthalmology at Zhongda Hospital, Southeast University, where she conducted her master’s thesis on retinal diseases under the supervision of Prof. Jie Luan. In 2025, she started her doctoral studies in the Mure Lab at the University of Bern, investigating ipRGCs’ alterations in mouse models of Diabetic Retinopathy.
Sabrina Briguglio obtained her Bachelor’s degree in Medical Biotechnology and her Master’s degree in Medical Biotechnology and Molecular Medicine at the University of Milan. In 2025, she completed her PhD in Experimental Medicine at the same institution, under the supervision of Prof. Flavia Antonucci, investigating the role of ATM in the pathophysiology of Major Depressive Disorder (MDD). Following her PhD, she continued her research as a postdoctoral researcher, focusing on completing and expanding the work developed during her doctoral studies. She is now a postdoctoral researcher at the University of Bern, working under the supervision of Dr. Ludovic Mure.
Chiara Bartolucci earned her master’s degree in Medical and Pharmaceutical Biotechnology from the University of Pavia in 2025. Her thesis investigated the effects of peripheral inflammation on the central nervous system in a mouse model of ulcerative colitis. She then joined the Institute of Neuropathology at the University Hospital Zurich as a predoctoral fellow, contributing to a collaborative project with Novartis and Tsinghua University on the generation and validation of single-colony-derived versions of arrayed CRISPR libraries for genome-wide activation, deletion, and silencing of human protein-coding genes. In 2026, she began her PhD in the Mure Lab at Inselspital and the University of Bern. Her research focuses on the vulnerability of ipRGCs in Alzheimer’s disease and the resulting effects on light-dependent behavioural responses.